Keurig Dr Pepper (KDP) Could Be 17% Undervalued After Board Pick For Split
Keurig Dr Pepper (KDP) has drawn fresh attention after appointing Cardinal Health Chief Financial Officer Aaron Alt to its board as the company prepares to separate into two independent businesses.
See our latest analysis for Keurig Dr Pepper.
The latest board appointment comes at a time when Keurig Dr Pepper’s share price has eased, with a 7 day share price return of 3.87% and a 30 day share price return of 5.41%. At the same time, a year to date share price return of 6.6% and a 90 day share price return of 1.58% indicate only modest positive momentum, while the 1 year total shareholder return has declined 12.25%.
If this kind of corporate reshaping has your attention, it may be a moment to broaden your watchlist with other potential ideas using the 19 top founder-led companies
For Keurig Dr Pepper, a new board voice and an upcoming split put the focus on timing. Does a reset after weaker recent shareholder returns present a reasonable entry now, or is it worth waiting for clearer pricing on each business?
Most Popular Narrative: 17.1% Undervalued
The most followed Keurig Dr Pepper narrative places fair value at about $35.65 per share, compared with the last close of $29.56. That gap rests on specific growth, margin and valuation assumptions that go well beyond the immediate share price pullback.
Market share gains in iconic liquid refreshment beverage brands, such as Dr Pepper and Canada Dry, alongside newer brands like Electrolit and C4, could drive revenue growth due to increased consumer demand and successful product introductions.
The integration of GHOST Energy and the establishment of an energy platform with significant market share are expected to contribute to revenue growth, thanks to expanded distribution and solid partnerships.
Want to see why this narrative still arrives at a higher fair value for Keurig Dr Pepper despite softer recent margins and slower coffee growth assumptions? The story hinges on a specific blend of beverage segment expansion, measured revenue growth and a future earnings multiple that lines up with those forecasts, not today’s headlines.
Result: Fair Value of $35.65 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Keurig Dr Pepper still faces pressure from weaker U.S. Coffee trends and higher input costs, which could limit how much value the separation ultimately reveals.
Find out about the key risks to this Keurig Dr Pepper narrative.
Another View on Keurig Dr Pepper’s Valuation
The most popular Keurig Dr Pepper narrative leans on a fair value of $35.65, supported by detailed growth and margin forecasts. Yet the current P/E of about 29.9x sits above a peer average of 24.9x and a fair ratio of 25.2x. This points to a richer price tag and potential valuation risk if expectations soften.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Unsure how to weigh Keurig Dr Pepper’s mix of pressures and potential? Take a close look at the details yourself and factor in the 3 key rewards and 4 important warning signs.
Looking for more investment ideas beyond Keurig Dr Pepper?
If you like the thesis around Keurig Dr Pepper but do not want to rely on a single stock, it makes sense to widen your opportunity set with focused screeners.
- Target higher quality at sensible prices by scanning for companies flagged in the 49 high quality undervalued stocks.
- Strengthen your income stream by checking out companies highlighted in the 9 dividend fortresses.
- Dial down portfolio risk by reviewing stocks identified in the 85 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com